Literature DB >> 10444552

Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity.

L Mantha1, E Palacios, Y Deshaies.   

Abstract

The involvement of glucocorticoids (GC) in the development of diet-induced obesity and in the concomitant adaptations of triglyceride (TG)-rich lipoprotein metabolism were examined. Rats were fed either rodent chow, which maintains a low lipid flux, or a diet high in sucrose and fat (HSF) that increases lipid flux, leading to metabolic perturbations similar to those that define the plurimetabolic syndrome in humans. The GC status was manipulated through adrenalectomy (ADX) and corticosterone (Cort) replacement. Compared with chow, the HSF diet increased energy intake (17%) and whole body (8%) and adipose tissue (80%) weights. The HSF diet also increased the acute postprandial rise in plasma insulin (4-fold) and TG (3-fold), fasting liver TG content (3-fold), triglyceridemia (54%), and adipose tissue lipoprotein lipase (LPL) activity (2-fold). ADX decreased energy intake and whole body and adipose tissue weights in both dietary cohorts, but more so in HSF-fed than in chow-fed animals. These ADX-induced effects were totally prevented by Cort replacement in rats fed chow, but only partially so in those fed the HSF diet in proportion to the degree of restoration of energy intake. In the chow-fed cohort, the above indexes of TG metabolism remained unaffected by the Cort status, whereas in the HSF-fed cohort, these variables were decreased by ADX to levels of chow-fed animals. Cort replacement in the HSF-fed animals restored indexes of TG metabolism to intact levels and reestablished the diet-related differences observed in intact animals. These findings indicate that GC modulate fasting TG metabolism only minimally when a diet that maintains a low lipid flux is fed. In contrast, their presence is a necessary condition for the development of diet-induced obesity and the concomitant alterations in insulin sensitivity and TG-rich lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444552     DOI: 10.1152/ajpregu.1999.277.2.R455

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism.

Authors:  Petra Wiedmer; Nilika Chaudhary; Michaela Rath; Chun-Xia Yi; Gayathri Ananthakrishnan; Rubén Nogueiras; Eva K Wirth; Henriette Kirchner; Ulrich Schweizer; Wenke Jonas; Christelle Veyrat-Durebex; Francoise Rohner-Jeanrenaud; Annette Schürmann; Hans-Georg Joost; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Physiol Behav       Date:  2011-10-28

2.  Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.

Authors:  Xuewen Wang; Faidon Magkos; Bruce W Patterson; Dominic N Reeds; Janine Kampelman; Bettina Mittendorfer
Journal:  Eur J Endocrinol       Date:  2012-05-22       Impact factor: 6.664

3.  A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.

Authors:  Nicole P Bowles; Ilia N Karatsoreos; Xiaosong Li; V Kiran Vemuri; Jodi-Anne Wood; Zhiying Li; Kellie L K Tamashiro; Gary J Schwartz; Alexandros M Makriyannis; George Kunos; Cecilia J Hillard; Bruce S McEwen; Matthew N Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

4.  Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.

Authors:  Vernon W Dolinsky; Donna N Douglas; Richard Lehner; Dennis E Vance
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

5.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

6.  Disengaging insulin from corticosterone: roles of each on energy intake and disposition.

Authors:  James P Warne; Susan F Akana; Abigail B Ginsberg; Hart F Horneman; Norman C Pecoraro; Mary F Dallman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

7.  Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.

Authors:  Frédéric Picard; Denis Arsenijevic; Denis Richard; Yves Deshaies
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat.

Authors:  Pascal Degrace; Laurent Demizieux; Joseph Gresti; Marcelline Tsoko; Agnès André; Luc Demaison; Pierre Clouet
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

9.  Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Tak Yung Man; Zoi Michailidou; Adnan Gokcel; Lynne Ramage; Karen E Chapman; Christopher J Kenyon; Jonathan R Seckl; Nicholas M Morton
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-15       Impact factor: 4.310

10.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.